Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Weight Loss 1Preleukemia 1Ovarian Neoplasms 1Osteochondroma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Nevus, Epithelioid and Spindle Cell 1Myelodysplastic Syndromes 1Malnutrition 1Lung Neoplasms 1Hematologic Neoplasms 1Glioblastoma 1Giant Cell Tumors 1Gastrointestinal Neoplasms 1Fibrosis 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Merkel Cell 1Carcinoma, Lobular 1Carcinoma in Situ 1Barrett Esophagus 1

Interventions

Blood Specimen Collection 8Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Tenofovir 3Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1peginterferon alfa-2a 1navitoclax 1maltodextrin 1hepatitis B hyperimmune globulin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1adefovir dipivoxil 1Viusid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Sampling Studies × Clear all
NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Dana-Farber Cancer Institute

Recruiting
5,000 enrolled
GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡